The human umbilical cord that originates from the embryo is an extra-embryonic membrane
and the Wharton's jelly within it is a rich source of stem cells (hWJSCs). It is not definitely …

The greatest therapeutic promise of human embryonic stem cells (hESC) is to generate
specialized cells to replace damaged tissue in patients suffering from various degenerative …

The application of human embryonic stem (ES) cells in medicine and biology has an
inherent reliance on understanding the starting cell population. Human ES cells differ from …

Induced pluripotent stem cells (IPSCs), with their unlimited regenerative capacity, carry the
promise for tissue replacement to counter age‐related decline. However, attempts to realize …

The neuronal repressor REST (RE1-silencing transcription factor; also called NRSF) is
expressed at high levels in mouse embryonic stem (ES) cells, but its role in these cells is …

Stem cells (SC) are able to self-renew and to differentiate into many types of committed cells,
making SCs interesting for cellular therapy. However, the pool of SCs in vivo and in vitro …

Microarray technology provides a unique opportunity to examine gene expression patterns
in human embryonic stem cells (hESCs). We performed a meta-analysis of 38 original …

Several reports have documented the derivation of pluripotent cells (multipotent germline
stem cells) from spermatogonial stem cells obtained from the adult mouse testis. These …

Adult tissue-derived mesenchymal stem cells (MSCs) have demonstrated therapeutic
efficacy in treating diseases or repairing damaged tissues through mechanisms thought to …

Future therapeutic applications of differentiated human embryonic stem cells (hESC) carry a
risk of teratoma formation by contaminating undifferentiated hESC. We generated 10 …